TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS · Delayed Price · Currency is USD
0.2900
+0.0100 (3.57%)
Aug 6, 2025, 4:00 PM EDT

Accolade Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1413--
Upgrade
Market Cap Growth
207.56%207.56%-52.84%---
Upgrade
Enterprise Value
152-0--
Upgrade
Last Close Price
0.3310.32507.2012320.00--
Upgrade
PS Ratio
---0.63--
Upgrade
PB Ratio
0.181.120.407.32--
Upgrade
P/TBV Ratio
0.211.330.52---
Upgrade
Debt / Equity Ratio
0.500.500.678.39-1.00-0.90
Upgrade
Asset Turnover
---0.400.260.23
Upgrade
Quick Ratio
0.450.450.750.720.140.46
Upgrade
Current Ratio
1.391.391.200.810.190.53
Upgrade
Return on Equity (ROE)
-426.84%-426.84%-391.64%---
Upgrade
Return on Assets (ROA)
-92.84%-92.84%-88.01%-78.20%-59.57%-49.45%
Upgrade
Return on Capital (ROIC)
-178.14%-178.14%-234.32%-474.25%--1491.58%
Upgrade
Earnings Yield
-2226.20%-359.27%-546.39%-54.21%--
Upgrade
FCF Yield
-2313.55%-373.36%-985.60%-640.98%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.